Technosphere inhaled insulin reduces postmeal glucose excursions

By GCDTR

ResearchFirst shared on LinkedIn

Share
Technosphere inhaled insulin reduces postmeal glucose excursions

A recent study co-authored by GCDTR researchers has compared postprandial glucose excursions between inhaled technosphere insulin (TI) and subcutaneous rapid-acting analog (RAA) insulin in adults with type 1 diabetes. The findings reveal that TI offers better postmeal glucose control, with smaller glucose excursions, lower peak glucose levels, and a shorter time to peak glucose compared to RAA.

These results could have significant implications for improving diabetes management strategies. Explore the full study to learn more: lnkd.in/ebiWgPSE DiabetesResearch InsulinTherapy Endocrinology

Read the full article

Back to News
Share

More from GCDTR

All news

Research

Dr. Jacob Kariuki receives NIH R01 for PATH activity program

Congratulations to Dr. Jacob Kariuki (Kigo Kariuki), Associate Professor at Nell Hodgson Woodruff School of Nursing at Emory University on receiving an NIH R01 award to advance his research on Physical Activity for The Heart (PATH)!

Research

Congratulations to GCDTR, Director and Emory Global Diabetes Research Center, Director of Data Analytics & Reporting, Dr....

Congratulations to GCDTR, Director and Emory Global Diabetes Research Center, Director of Data Analytics & Reporting, Dr. Jeff Mills, Ed.D, MBA on receiving an National Science Foundation (NSF)-supported ACCESS Discovery Project! ACCESS is a National Science Foundation-supported program that connects…

Research

Roy Beck identifies donor damage and complications increase DMEK cell loss

What factors influence corneal graft health after Descemet membrane endothelial keratoplasty (DMEK)?